http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101771151-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-465 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-465 |
| filingDate | 2015-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101771151-B1 |
| titleOfInvention | Pharmaceutical composition for preventing or treating chondrogenic disease comprising nicotinamides |
| abstract | The present invention relates to a pharmaceutical composition for preventing or treating cartilage damage diseases comprising nicotinamide (NAM) as an active ingredient. More particularly, the present invention relates to a pharmaceutical composition for preventing or treating cartilage damage diseases, which comprises nicotinamide in a human bone marrow mesenchymal stem cell (hBMSC) The nicotinamide promotes chondrogenic differentiation and thus can be useful as a pharmaceutical composition for preventing or treating cartilage damage diseases. Respectively. |
| priorityDate | 2015-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 126.